Top Banner

of 36

16691_glomerulopati Bengkulu April 2015

Jul 07, 2018

Download

Documents

Fegi Nugraha
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
  • 8/18/2019 16691_glomerulopati Bengkulu April 2015

    1/36

    Kuliah Glomerulopati

    pada anak

     Muhammad HeruMuryawan,dr,SpA(K)

  • 8/18/2019 16691_glomerulopati Bengkulu April 2015

    2/36

    Pokok bahasan

    Glomerulopati1. Sindrom nerotik

    !. Glomeruloneritis

  • 8/18/2019 16691_glomerulopati Bengkulu April 2015

    3/36

    Ge"ala #an##uan #in"al anak yan#serin# di"umpai

    • $dema

    • %enal

    • Kardial• Hepatal

    • &utrisional

    • Hematuria (#in"al'di luar #in"al)

    • Proteinuria

    • Hipertensi (primer'sekunder)

    • Penurunan a"u ltrasi #lomerulus.

  • 8/18/2019 16691_glomerulopati Bengkulu April 2015

    4/36

    G*M$%+*PAH-

    MA& /A+S$ *0 K&$- 0A+%$ & /H%$&

    $0&*&2 in3amatory 4han#es in #lomerulus due to

    immunolo#i4 me4hanism

    /&/A MA&0$SA*&S•  solated proteinuria

    •  Proteinuria 5 edema (i.e.&ephroti4syndrome)

    •  solated haematuria•  Hypertension 5'6 proteinuria'haematuria

    •  %enal ailure

  • 8/18/2019 16691_glomerulopati Bengkulu April 2015

    5/36

    Classifcation

    /on#enital

    Primary'

    idiopathi4

    A47uired

    • Alport Syndrome• /on#enital &ephroti4 Syndrome

    Se4ondary

    1. Minimal change (MCNS)2. Focal segmentalglomerulosclerosis3. Mesangial prolierativeglomerulonephriti4. Memrano!prolierativeglomerunephritis

    ". Memranous glomerulonephritis#. $g% Nephropath&'. lomerulonephritis others

    •   ost $nection * ost streptococcalglomerulonephritis

    •   Mulis&stem +iseases, -/ 0S•   $ntoicaation, +rugs/ metal•   Neoplasms

  • 8/18/2019 16691_glomerulopati Bengkulu April 2015

    6/36

    Massi8e Proteinuria6 9 :; m#'k# body wei#ht 'day,or6 9 !,: #'d

    $dema

    Hyperlipidemia (=!;;m#?)

    Roth KS. Nephrotic syndrome: Pathogenesis and management. Ped in Rev 2002;23(7):237!7

    Nephrotic S&n+rome

  • 8/18/2019 16691_glomerulopati Bengkulu April 2015

    7/36

    $pidemiolo#y

    • n4iden4e – n4iden4e !6@ new 4ases per 1;,;;;

     – Pre8alen4e 1:.@ 4ases per 1;,;;;

    • A#e – M/ !.: years median a#e

     – 0SGS years median a#e

    • SeB – C2! DoysE Girls in 4hildren > yo

     – $7ual ratio in those older

  • 8/18/2019 16691_glomerulopati Bengkulu April 2015

    8/36

    /lassi4ation1. /on#enital.!. Primary nephroti4 syndrome

     he term applied to disease limited tothe kidney

    • Minimal 4han#e, lipoid disease, nildisease• 0o4al se#mental s4hlerosis• Membranous nephropathy

    • Prolierati8e nephritis (mesan#ial,o4al, diFuse)

    C. Se4ondary nephroti4 syndrome• upus nephritis

    • Heno4h6S4honlein purpura

  • 8/18/2019 16691_glomerulopati Bengkulu April 2015

    9/36

    /lassi4ation o &ephroti4 syndrome

    Response to steroid

    "arratt #$. Steroid responsive nephrotic syndrome. %n: "arratt #$& editor. Pediatric nephro'ogy. !th

     edition. "a'timore:ippincot i'iams * i'+ins;,---. p. 732.

  • 8/18/2019 16691_glomerulopati Bengkulu April 2015

    10/36

    CONGENITAL NEPHROTIC SYNDROME

     4lini4al onset in the rst C months o lie

     proteinuria in utero or at birth  ele8ated amnioti4 3uid le8el o alpha6etoprotein  beore !; weeks #estation  /lassi4ation 2

     Primary   0innish type  iFuse mesan#ial s4lerosis  Minimal 4han#es &S  0o4al se#mental #lomerulos4lerosis

     Secondary  4on#enital syphilis, toBoplasmosis, 4ytome#alo8irus  - #onadal dys#enesis and Iilms tumour  nephroblastoma  et4

  • 8/18/2019 16691_glomerulopati Bengkulu April 2015

    11/36

    Etiologi

    J; ? idiopathi4 nephroti4 syndrome

    @: ? minimal 4han#e nephroti4 syndrome(M/&S)

    1; ? o4al se#mental #lomerulos4lerosis(0SGS)

    > : ? membranous nephropathi

    1; ? Membrano prolierati8e

    #lomerulonephritis

    *PAH/'P%MA%-&$PH%*/ S-&%*M$

  • 8/18/2019 16691_glomerulopati Bengkulu April 2015

    12/36

    $M$-5 

  • 8/18/2019 16691_glomerulopati Bengkulu April 2015

    13/36

     Pathophysiology

     he underlyin# patho#eneti4 abnormalityo &S is proteinuria due to an in4rease in

    #lomerular 4apillary wall permeability.

    1. he 4apillary wall loss the ne#ati8e4har#e

      #ly4oprotein barries!. n4rease #lomerular permeability to

    proteins

  • 8/18/2019 16691_glomerulopati Bengkulu April 2015

    14/36

    Gambar 1. Penampan# #in"al

  • 8/18/2019 16691_glomerulopati Bengkulu April 2015

    15/36

    Patosiolo#i S&

    Kehilan#an muatan ne#ati i membran basalis

    Proteinuria

    Hipoalbunemiahiperkolesterolemia

      edema

  • 8/18/2019 16691_glomerulopati Bengkulu April 2015

    16/36

    n prin4iple edema may de8elop

    by two me4hanism 2

    A. he 4apillary hydrauli4 pressurein4reases as a result o 4onstant

    ele8ation o plasma 8olume 2o8er3owL 4on4ep (nehpriti4edema)

    D. he 4olloid osmoti4 pressure inplasma drops 2 underllin# theory (nephroti4 edema

  • 8/18/2019 16691_glomerulopati Bengkulu April 2015

    17/36

      Nephritic e+ema Nephrotice+ema

      %enal salt and water %lteration oStarling orces  retention (Capillar& colloi+ osmotic 

    pressure )

      $Bpansion o 4ir4ulatory 8olume $dema ormation

    Alteration o Starlin# or4es olume 4ontra4tion(/apillary hydrauli4 pressure ↑)

    $dema ormation %enal salt and waterretention  Proposed s4heme o edema ormation in

    patiens with #lomerular disease

  • 8/18/2019 16691_glomerulopati Bengkulu April 2015

    18/36

    Clinical manifestation

    $+iopathic nephrotic s&n+rome

    • Pre8alen4y male 2 emale N ! 2 1• Most 4ommonly between the a#e o !&  ys

    • $dema, initially noted around theeyes, and in the lower eBtremities is pittin#L. t be4omes #eneraliOed

  • 8/18/2019 16691_glomerulopati Bengkulu April 2015

    19/36

    Generelised edema(anasar4a)

  • 8/18/2019 16691_glomerulopati Bengkulu April 2015

    20/36

    Older child withnephrotic !ndro"e

    Pittin# peripher$loede"$

  • 8/18/2019 16691_glomerulopati Bengkulu April 2015

    21/36

    &ephroti4 Syndrome

    As4ites

  • 8/18/2019 16691_glomerulopati Bengkulu April 2015

    22/36

  • 8/18/2019 16691_glomerulopati Bengkulu April 2015

    23/36

    Laboratory Test in N S

     o 4onrm &SSerum (albumin, #lobulin, 4holesterol)+rine protein 2 7ualitati8e (dipsti4k 2 albumin)

      7uantitati8e (!

  • 8/18/2019 16691_glomerulopati Bengkulu April 2015

    24/36

  • 8/18/2019 16691_glomerulopati Bengkulu April 2015

    25/36

    Management

    A. General Prin4iples• &o sistemati4 dietary ad8i4e is ne4essaryin simple 4ases o S%&S

    • Antibioti4 is indi4ated in 4ellulitis, peritonitis, septi4emia,et4.• iureti42 $dematous 4hild in the absen4e o hypo8olemia

    diureti4 2 urosemide (16! m# 'k#DI'day)• Albumin inusions 2 $Bpensi8e 4an haOardous but may belie sa8in#, its indi4ations in4lude 2

    • Hypo8olemia (abdominal pain, hypotension, oli#uria)• %enal insuQ4ien4y

    /ompli4ation 2Infections 2 S.pneumoniae, 4hi4kenpoB and measlesThrombocytosis 2 Hyper4oa#ulable state.

  • 8/18/2019 16691_glomerulopati Bengkulu April 2015

    26/36

     %$AM$&

    1. Medi4ation

    1. S$%*

    !. +%$/S

    C. MM+&*S+P%$SS$ AG$&S

    !. ietary (nephroti4 diet)

    *I SA (16! #'day)

    P%*$& !6C #'k#'day

  • 8/18/2019 16691_glomerulopati Bengkulu April 2015

    27/36

    8.Corticosteroi+

    • Prednisolon an a4ti8e metabolit o

    prednison.

    • Doth ha8e been widely used but

    remains un4lear whether their mode

    o a4tion is 6 anti6in3amatory,

    6 immunosupressi8e,

    6 or both

  • 8/18/2019 16691_glomerulopati Bengkulu April 2015

    28/36

    $nitial 7reatment

    a. ntrodu4tion o remission  Prednisolon ; m#'m!'day or ! m#'k#DI'

    day at least < weeks daily bein# re7uired

    b. Iithdrawal 2 here are two alternati8e 2  6 Modied SK/ re#imen 2

  • 8/18/2019 16691_glomerulopati Bengkulu April 2015

    29/36

    S7%N%6 76%7MN7C67$CS76$ (6N$SN)

    4 MINGGU

     IMMUNOSUPRESSIVE AGENTS

      Prednison FD: 60 mg/m2/day

      Prednison AD: 40 mg/m2/day

    REMISSION (-)  REMISSION (+)

     

    STEROID RESISTANT

    STEROID

    SENSITIVE

    4 MINGGU

     FULL DOSE    ALTERNATING 

    $N$7$%- 76%7MN7

    THE INTERNATIONAL COMMITTEE OF KIDNEY DISEASE IN CHILDREN (1967)

  • 8/18/2019 16691_glomerulopati Bengkulu April 2015

    30/36

  • 8/18/2019 16691_glomerulopati Bengkulu April 2015

    31/36

    Indications for hospital admission or patient with nephrotic syndrome

    • &ewly dia#nosed patiens

    • Se8ere dehydrations (poor intake,persistent 8omitin#)

    • +neBplained e8er (suspe4ted ba4terialine4tion)

    • %era4tory edema (respiratory distress)

    • Peritonitis

    • %enal insuQ4ien4y (ele8ated serum

    4reatinine)

  • 8/18/2019 16691_glomerulopati Bengkulu April 2015

    32/36

    utcome

    Mortality

     he mortality rate or S%&S is 1 to !,: ?usually rom sepsis, hypo8olemia, and

    thrombo4ytosis.

    %elapses

    n most 4ases the relapses e8entually

    4ease he earlier the onset o S%&S, the morelikely that the disease will be protra4ted

    enitions

  • 8/18/2019 16691_glomerulopati Bengkulu April 2015

    33/36

    enitions

    • %emission – +rinary protein > < m#' m!hr or AlbustiB N

    ;'ra4e or C 4onse4uti8e days

    • Steroid %esponsi8e

     – %emission with steroids alone

    • %elapse – +rinary protein =

  • 8/18/2019 16691_glomerulopati Bengkulu April 2015

    34/36

    • Steroid ependen4e – wo 4onse4uti8e relapses o44urrin#

    durin# 4orti4osteroid treatment or within

    1< days o its 4essation• Steroid %esistan4e

     –  0ailure to a4hie8e response in spite o <

    weeks o prednisone ; m#'m!

    day

  • 8/18/2019 16691_glomerulopati Bengkulu April 2015

    35/36

  • 8/18/2019 16691_glomerulopati Bengkulu April 2015

    36/36

    6NS$S

    6N%- FNC7$N gra+uall&

      ailure

    rapi+/ aout" * 1> &ears